Long-Term Care

Scientists produce potential Alzheimer’s disease treatment of the cocktail variety

Contemporary Long-Term Care Weekly, January 14, 2010

A nutritional cocktail, called Souvenaid, is believed to help restore the synapses (the junctions between neurons or between a neuron and muscle) in a person’s brain. The recent development could prove to be extremely beneficial to people suffering from Alzheimer’s disease or dementia, as research shows a correlation between low numbers of synapses and memory impairment, according to CNN.

The drink, known as a "medicinal food" because it is authorized by a physician and is intended to affect a specific condition, contains uridine, choline, and the omega-3 fatty acid DHA. All three nutrients already exist in the human body, but it is their interaction in the correct proportions that’s believed to produce the proteins required for the restoration of synapses, based on the study co-authored by Dr. Richard Wurtman of the Massachusetts Institute of Technology. Future clinical studies involving Souvenaid and Alzheimer’s patients are planned to gain a better understanding of the cocktail’s capabilities.

Most Popular

Related Articles